1-Methyl-5-(tri-n-butylstannyl)imidazole

CAS147716-03-8
EC641-307-5

List details

Basic info

Status Opinion Adopted
Submitter Germany
Regulatory programme
  • Chemical registered under REACH
ATP number and date ATP07 - (25/07/2015), 01/01/2017
Link to ATP

Classification

Harmonised classification at the time of the proposal
  • Acute Tox. 3*, H301
  • Acute Tox. 4*, H312
  • Skin Irrit. 2, H315
  • Eye Irrit. 2, H319
  • STOT RE 1, H372**
  • Aquatic Acute 1, H400
  • Aquatic Acute 1, M-factor=10
  • Aquatic Chronic 1, H410
  • Aquatic Chronic 1, M-factor=10
Proposed harmonised classification by the dossier submitter
  • Acute Tox. 3, H301
  • Acute Tox. 3, H311
  • Skin Irrit. 2, H315
  • Eye Irrit. 2, H319
  • Repr. 1B, H360FD
  • STOT RE 1, H372
  • Aquatic Acute 1, H400
  • Aquatic Acute 1, M-factor=10
  • Aquatic Chronic 1, H410
  • Aquatic Chronic 1, M-factor=10
Specific concentration limits at the time of the proposal STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,25 % ≤ C < 1 % Skin Irrit. 2; C ≥ 1 % Eye Irrit. 2; C ≥ 1 %

Intention timeline

Date of intention 2012-01-05
Submitted for accordance check 2012-01-05
Final submission date 2013-04-25
Start of consultation 2013-06-06
Deadline for commenting 2013-07-22
Date of opinion 2013-12-05
Legal deadline for opinion adoption 2014-12-05

Documents

CLH report
Comments received
RAC opinion
Background document

Related substances

No substances related to this record were found in our database.

Related regulatory records

  • There are no related (i.e. sharing the same name or identifier) regulatory records in our database